From: Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Fusion gene | Exon ratio (fusion gene/RAF1) | Associated cancers | Ref. |
---|---|---|---|
MBNL-1 | EX 1-8 : EX 8-17 | Langerhans cell histiocytosis | [9] |
TMF1 | EX 1-13 : EX 10-17 | Sarcoma, NOS | |
QKI | EX 1-3 : EX 8-17 | Pilocytic Astrocytoma | |
SOX6 | EX 1-6 : EX 8-17 | High-grade glioma, NOS | |
FYCO-1 | CRAF intron 5: FYCO-1 intron11 | Multi-metastatic melanoma, sensitive to MEK inhibitors | [10] |
GOLGA-4 | EX 1-12 : EX 10-17; EX 1-21 : EX 8-17; EX 1-5/1-14 : EX 8-17; EX 1-17 : EX 8-17 | Desmoplastic infantile ganglioglioma; Cutaneous melanoma, sensitive to MEK inhibitors; Melanoma; Pancreatic acinar cell carcinomas | |
NFIA | EX 1-6 : EX 9-17 | Pilocytic astrocytoma | [14] |
SRGAP3 | EX 1-10 : EX 9-17; EX 1-12 : EX 10-17 | Low grade glioma, NOS; Pilocytic astrocytoma | |
LRCH3 | EX 1-12/1-13 : EX 8-17 | Melanoma | [12] |
CTDSPL | EX 1-2 : EX 8-17 | Melanoma | |
MAP4 | EX 1-13/1-15 : EX 8-17 | Melanoma | |
PRXAR2A | EX 1-8/1-9 : EX 8-17 | Melanoma | |
CTNNA1 | EX 1-6 : EX 8-17 | Pancreatic acinar cell carcinomas | [11] |
GATM | EX 1-2 : EX 10-17 | Pancreatic acinar cell carcinomas | |
PDZRN3 | EX 1-5 : EX 8-17 | Pancreatic acinar cell carcinomas | |
HERPUD1 | EX 1-8 : EX 8-17 | Pancreatic acinar cell carcinomas | |
TRIM33 | EX 1-11 : EX 8-17 | Pancreatic acinar cell carcinomas | |
LRRFIP2 | EX 1-20 : EX 8-17 | Acral Melanoma | [16] |
PDZRN3 | EX 1-5 : EX 10-17 | Spindle cell tumors | |
SLMAP | EX 1-10 : EX 8-17 | Spindle cell tumors | [17] |
MTAP | EX 1-7 : EX 8-17 | Soft tissue sarcoma | [19] |
ATG7 | EX 1-18 : EX 8-17 | Glioblastoma; Anaplastic pleomorphic xanthoastrocytoma |